Skip to content

Sigma Pharmaceuticals Ltd Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Wed, Feb 24, 2027 · estimates and history

Sigma Pharmaceuticals Ltd · E.SIG.AU · Australia
Use symbol E.SIG.AU in our API & Excel add-in to retrieve this data ↓
2.89
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 0%
Trend 75%
Bubble Risk LOW
Realised Volatility (20D) 12.38%

Sigma Pharmaceuticals Ltd Forecast

Sigma Pharmaceuticals Ltd short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 12.4% a year, a typical one-standard-deviation range is 2.8396–2.9404 over a week, 2.7867–2.9933 over a month and 2.5323–3.2477 over a year. (Signals as of 21 Nov 2026.)

Sigma Pharmaceuticals Ltd Price Chart

MacroFinance.ai

Sigma Pharmaceuticals Ltd Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Sigma Pharmaceuticals Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Sigma Pharmaceuticals Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Sigma Pharmaceuticals Ltd
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Sigma Pharmaceuticals Ltd
P/E
36.49x
Mid-range vs own history
QoQ −0.3%
YoY −79.4%
now 36.489832.2 low179.78 high
ⓘP/E As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Sigma Pharmaceuticals Ltd
P/S
1.86x
Mid-range vs own history
QoQ −0.3%
YoY −44.4%
now 1.85561.64 low3.39 high
ⓘP/S As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Sigma Pharmaceuticals Ltd
P/B
6.66x
Cheap vs own history
QoQ −0.3%
YoY −11.8%
now 6.65865.88 low7.68 high
ⓘP/B As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Sigma Pharmaceuticals Ltd
EV/EBITDA
24.16x
Mid-range vs own history
QoQ −0.3%
YoY −73.0%
now 24.16321.47 low91.09 high
ⓘEV/EBITDA As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Sigma Pharmaceuticals Ltd
EV/Sales
1.96x
Mid-range vs own history
QoQ −0.3%
YoY −44.2%
now 1.9611.74 low3.57 high
ⓘEV/Sales As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Sigma Pharmaceuticals Ltd
FCF Yield
1.4%
Strong vs own history
QoQ +0.3%
YoY −450.0%
now 1.3574-0.4 low1.54 high
ⓘFCF Yield As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Sigma Pharmaceuticals Ltd
Earnings Yield
2.7%
Mid-range vs own history
QoQ +0.3%
YoY +384.5%
now 2.74050.56 low3.11 high
ⓘEarnings Yield As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Sigma Pharmaceuticals Ltd
Dividend Yield
2.2%
Strong vs own history
QoQ +0.3%
YoY +114.4%
now 2.17591 low2.47 high
ⓘDividend Yield As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Sigma Pharmaceuticals Ltd
Market Cap
$33.3B
Mid-range vs own history
QoQ −0.3%
YoY −5.6%
now 33264.434229,351 low36,028 high
ⓘMarket Cap As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Sigma Pharmaceuticals Ltd
Net Debt
$1.9B
Mid-range vs own history
QoQ 0.0%
YoY −2.2%
now 1889.4241,889 low2,881 high
ⓘNet Debt As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Sigma Pharmaceuticals Ltd
Net Debt / EBITDA
1.30x
1.30x
QoQ 0.0%
YoY −72.1%
now 1.29871.3 low4.66 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Sigma Pharmaceuticals Ltd
Current Ratio
1.67x
Mid-range vs own history
QoQ 0.0%
YoY −2.1%
now 1.67131.67 low1.71 high
ⓘCurrent Ratio As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Sigma Pharmaceuticals Ltd
Quick Ratio
1.06x
Mid-range vs own history
QoQ 0.0%
YoY −4.1%
now 1.06361.06 low1.11 high
ⓘQuick Ratio As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Sigma Pharmaceuticals Ltd
Interest Coverage
19.63x
19.63x
QoQ 0.0%
YoY +65.9%
now 19.632711.83 low19.63 high
ⓘInterest Coverage As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Sigma Pharmaceuticals Ltd
Debt / Equity
0.40x
Mid-range vs own history
QoQ 0.0%
YoY −8.8%
now 0.40450.4 low0.62 high
ⓘDebt / Equity As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Sigma Pharmaceuticals Ltd
Piotroski F-Score
3
3
QoQ 0.0%
YoY +50.0%
now 32 low3 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Sigma Pharmaceuticals Ltd
Altman Z-Score
7.23
Mid-range vs own history
QoQ −0.2%
YoY −3.3%
now 7.2346.69 low7.87 high
ⓘAltman Z-Score As of 22 Nov 2026.See Sigma Pharmaceuticals Ltd returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  14 members-only factors: FCF Growth, Earnings Surprise, Estimate Revision 30D, Forward P/E and moreSign up
Accounting Red Flags
  17 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Sigma Pharmaceuticals Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Sigma Pharmaceuticals Ltd fundamentals: income statement, balance sheet & cash flow

Sigma Pharmaceuticals Ltd reported revenue of 10.83bn AUD and net income of 709.2m AUD in FY2026, the year ended 31 January 2026 — revenue up 121.4% and net income up 33.8% on the prior year. Free cash flow was 517.9m AUD. These figures are as reported in the filings, not restated: 27 fiscal years and 99 quarters of history, back to January 2000.

Revenue (FY2026)
10.83bn AUD
+121.4%
Net income
709.2m AUD
+33.8%
Gross margin
18.06%
Free cash flow
517.9m AUD
+260.1%
Net debt
1.89bn AUD
Sigma Pharmaceuticals Ltd income statement, annual, as reported · AUD billions unless stated
AUD billionsFY2026FY2025FY2024FY2023FY2022
Period end31 Jan 202631 Jan 202531 Jan 202431 Jan 202331 Jan 2022
Revenue10.834.893.323.663.45
Cost of revenue8.884.563.133.443.25
Gross profit1.960.330.190.220.20
Selling, general & admin.0.460.380.090.080.09
Operating income1.000.72-0.07-0.07-0.11
EBITDA1.080.090.050.050.03
Interest expense0.110.020.020.010.01
Pre-tax income1.010.740.010.01-0.01
Income tax0.300.220.000.000.00
Net income0.710.530.000.00-0.01

Download Sigma Pharmaceuticals Ltd fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.SIG.AU&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 27 fiscal years and 99 quarters, the filing vintages behind each number and API access.
Create free account

Figures in AUD, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Sigma Pharmaceuticals Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Sigma Pharmaceuticals Ltd Trading Strategies

31 backtested tactical asset allocation strategies hold EFA (developed markets outside the US), the closest tradable exposure to Sigma Pharmaceuticals Ltd; 22 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 31 strategies holding EFA →

Statistical Distribution of Returns

Plus

How Sigma Pharmaceuticals Ltd’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Sigma Pharmaceuticals Ltd behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Sigma Pharmaceuticals Ltd (Australia)

Sigma Pharmaceuticals Ltd is a listed security in Australia. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Scandinavian Investment Group A/S

Frequently asked questions

What is Sigma Pharmaceuticals Ltd?
Sigma Pharmaceuticals Ltd is a listed security in Australia. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Sigma Pharmaceuticals Ltd price?
The latest close is 2.89 (21 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Sigma Pharmaceuticals Ltd in an uptrend?
As of 21 Nov 2026, short-term momentum is neutral (2 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (7 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Sigma Pharmaceuticals Ltd?
20-day realised volatility is 12.4% a year (21 Nov 2026), which implies a typical one-standard-deviation move of about 3.6% over a month and 1.7% over a week.
What factors affect Sigma Pharmaceuticals Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Sigma Pharmaceuticals Ltd, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Sigma Pharmaceuticals Ltd?
31 backtested tactical asset allocation strategies trade Sigma Pharmaceuticals Ltd through EFA; 22 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Sigma Pharmaceuticals Ltd returns analysed?
The Statistical Distribution of Returns section shows the distribution of Sigma Pharmaceuticals Ltd daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Sigma Pharmaceuticals Ltd historical data?
In the Free historical data section of this page: the last 10 years of Sigma Pharmaceuticals Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Sigma Pharmaceuticals Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of Sigma Pharmaceuticals Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.SIG.AU&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-202.89
2026-11-192.89
2026-11-182.9
2026-11-172.9
2026-11-162.9
2026-11-132.89
2026-11-122.89
2026-11-112.91
2026-11-102.87
2026-11-092.85
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.